CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 2.99 USD 1.01%
Market Cap: 670.7m USD
Have any thoughts about
CureVac NV?
Write Note

CureVac NV
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CureVac NV
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
CureVac NV
NASDAQ:CVAC
Retained Earnings
€490.1m
CAGR 3-Years
-11%
CAGR 5-Years
73%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Retained Earnings
€20B
CAGR 3-Years
161%
CAGR 5-Years
207%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Retained Earnings
-€1.3B
CAGR 3-Years
-88%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Retained Earnings
-€598.9m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Retained Earnings
€268.1m
CAGR 3-Years
21%
CAGR 5-Years
3%
CAGR 10-Years
2%
Formycon AG
XETRA:FYB
Retained Earnings
€486.7m
CAGR 3-Years
106%
CAGR 5-Years
83%
CAGR 10-Years
N/A
No Stocks Found

CureVac NV
Glance View

Market Cap
670.8m USD
Industry
Biotechnology

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 500 full-time employees. The company went IPO on 2020-08-14. The firm is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The firm's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

CVAC Intrinsic Value
4.32 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is CureVac NV's Retained Earnings?
Retained Earnings
490.1m EUR

Based on the financial report for Dec 31, 2023, CureVac NV's Retained Earnings amounts to 490.1m EUR.

What is CureVac NV's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
73%

Over the last year, the Retained Earnings growth was -4%. The average annual Retained Earnings growth rates for CureVac NV have been -11% over the past three years , 73% over the past five years .

Back to Top